Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced? | Zendy

Theodora C van Tilborg | Zendy; I. A. P. Derks-Smeets | Zendy; Anna M.E. Bos | Zendy; Jan C. Oosterwijk | Zendy; Ron J. van Golde | Zendy; C E de Die-Smulders | Zendy; Lizet E. van der Kolk | Zendy; Wendy A.G. van Zelst–Stams | Zendy; Maria E. Velthuizen | Zendy; Annemieke Hoek | Zendy; Marinus J.C. Eijkemans | Zendy; Joop S.E. Laven | Zendy; Margreet G.E.M. Ausems | Zendy; Frank J. Broekmans | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?

Author(s) -

Theodora C van Tilborg,

I. A. P. Derks-Smeets,

Anna M.E. Bos,

Jan C. Oosterwijk,

Ron J. van Golde,

C E de Die-Smulders,

Lizet E. van der Kolk,

Wendy A.G. van Zelst–Stams,

Maria E. Velthuizen,

Annemieke Hoek,

Marinus J.C. Eijkemans,

Joop S.E. Laven,

Margreet G.E.M. Ausems,

Frank J. Broekmans

Publication year - 2016

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dew242

Subject(s) - anti müllerian hormone , brca mutation , medicine , ovarian reserve , confounding , mutation , gynecology , hormone , infertility , cross sectional study , ovarian cancer , obstetrics , oncology , cancer , genetics , pregnancy , biology , gene , pathology

Do BRCA1/2 mutation carriers have a compromised ovarian reserve compared to proven non-carriers, based on serum anti-Müllerian hormone (AMH) levels?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research